nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—CYP1A1—liver cancer	0.369	1	CbGaD
Norfloxacin—TOP2A—Epirubicin—liver cancer	0.194	0.41	CbGbCtD
Norfloxacin—TOP2A—Doxorubicin—liver cancer	0.103	0.218	CbGbCtD
Norfloxacin—CYP3A7—Sorafenib—liver cancer	0.0466	0.0984	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.0466	0.0984	CbGbCtD
Norfloxacin—CYP3A5—Sorafenib—liver cancer	0.035	0.0738	CbGbCtD
Norfloxacin—CYP1A2—Sorafenib—liver cancer	0.026	0.055	CbGbCtD
Norfloxacin—CYP3A4—Sorafenib—liver cancer	0.0136	0.0288	CbGbCtD
Norfloxacin—CYP3A4—Doxorubicin—liver cancer	0.00827	0.0175	CbGbCtD
Norfloxacin—Vaginal moniliasis—Doxorubicin—liver cancer	0.000737	0.00887	CcSEcCtD
Norfloxacin—Anorectal discomfort—Epirubicin—liver cancer	0.000735	0.00885	CcSEcCtD
Norfloxacin—Vulvovaginal mycotic infection—Epirubicin—liver cancer	0.000735	0.00885	CcSEcCtD
Norfloxacin—Lactic dehydrogenase activity increased—Doxorubicin—liver cancer	0.000727	0.00875	CcSEcCtD
Norfloxacin—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.000711	0.00856	CcSEcCtD
Norfloxacin—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.000711	0.00856	CcSEcCtD
Norfloxacin—Vulvovaginal candidiasis—Doxorubicin—liver cancer	0.000707	0.00852	CcSEcCtD
Norfloxacin—Blood lactate dehydrogenase increased—Epirubicin—liver cancer	0.000692	0.00833	CcSEcCtD
Norfloxacin—Dysphagia—Sorafenib—liver cancer	0.000682	0.00822	CcSEcCtD
Norfloxacin—Anorectal discomfort—Doxorubicin—liver cancer	0.00068	0.00819	CcSEcCtD
Norfloxacin—Vulvovaginal mycotic infection—Doxorubicin—liver cancer	0.00068	0.00819	CcSEcCtD
Norfloxacin—Pancreatitis—Sorafenib—liver cancer	0.000669	0.00805	CcSEcCtD
Norfloxacin—Serum creatinine increased—Epirubicin—liver cancer	0.000654	0.00787	CcSEcCtD
Norfloxacin—Blood lactate dehydrogenase increased—Doxorubicin—liver cancer	0.00064	0.0077	CcSEcCtD
Norfloxacin—Neutropenia—Sorafenib—liver cancer	0.000638	0.00768	CcSEcCtD
Norfloxacin—Serum creatinine increased—Doxorubicin—liver cancer	0.000605	0.00728	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.000603	0.00726	CcSEcCtD
Norfloxacin—Acute coronary syndrome—Sorafenib—liver cancer	0.0006	0.00722	CcSEcCtD
Norfloxacin—Renal failure—Sorafenib—liver cancer	0.000598	0.0072	CcSEcCtD
Norfloxacin—Myocardial infarction—Sorafenib—liver cancer	0.000597	0.00718	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Sorafenib—liver cancer	0.000597	0.00718	CcSEcCtD
Norfloxacin—Jaundice—Sorafenib—liver cancer	0.000593	0.00714	CcSEcCtD
Norfloxacin—Stomatitis—Sorafenib—liver cancer	0.000593	0.00714	CcSEcCtD
Norfloxacin—TOP2A—Doxorubicin—Epirubicin—liver cancer	0.000574	0.173	CbGdCrCtD
Norfloxacin—TOP2A—Daunorubicin—Epirubicin—liver cancer	0.000574	0.173	CbGdCrCtD
Norfloxacin—TOP2A—Idarubicin—Epirubicin—liver cancer	0.000574	0.173	CbGdCrCtD
Norfloxacin—Nystagmus—Epirubicin—liver cancer	0.000563	0.00678	CcSEcCtD
Norfloxacin—Blister—Epirubicin—liver cancer	0.000558	0.00671	CcSEcCtD
Norfloxacin—Ventricular arrhythmia—Epirubicin—liver cancer	0.000543	0.00654	CcSEcCtD
Norfloxacin—Albuminuria—Epirubicin—liver cancer	0.000538	0.00648	CcSEcCtD
Norfloxacin—TOP2A—Epirubicin—Doxorubicin—liver cancer	0.000531	0.16	CbGdCrCtD
Norfloxacin—TOP2A—Idarubicin—Doxorubicin—liver cancer	0.000531	0.16	CbGdCrCtD
Norfloxacin—TOP2A—Daunorubicin—Doxorubicin—liver cancer	0.000531	0.16	CbGdCrCtD
Norfloxacin—Nystagmus—Doxorubicin—liver cancer	0.000521	0.00627	CcSEcCtD
Norfloxacin—Erythema multiforme—Sorafenib—liver cancer	0.000517	0.00622	CcSEcCtD
Norfloxacin—Blister—Doxorubicin—liver cancer	0.000516	0.00621	CcSEcCtD
Norfloxacin—Tinnitus—Sorafenib—liver cancer	0.000509	0.00613	CcSEcCtD
Norfloxacin—Ventricular arrhythmia—Doxorubicin—liver cancer	0.000503	0.00605	CcSEcCtD
Norfloxacin—Albuminuria—Doxorubicin—liver cancer	0.000498	0.006	CcSEcCtD
Norfloxacin—Glycosuria—Epirubicin—liver cancer	0.000496	0.00597	CcSEcCtD
Norfloxacin—Erythema—Sorafenib—liver cancer	0.000476	0.00572	CcSEcCtD
Norfloxacin—Dysgeusia—Sorafenib—liver cancer	0.000466	0.00561	CcSEcCtD
Norfloxacin—Glycosuria—Doxorubicin—liver cancer	0.000459	0.00553	CcSEcCtD
Norfloxacin—Jaundice cholestatic—Epirubicin—liver cancer	0.000458	0.00551	CcSEcCtD
Norfloxacin—Muscle spasms—Sorafenib—liver cancer	0.000457	0.0055	CcSEcCtD
Norfloxacin—Lacrimation increased—Epirubicin—liver cancer	0.000436	0.00525	CcSEcCtD
Norfloxacin—Angioedema—Sorafenib—liver cancer	0.000435	0.00523	CcSEcCtD
Norfloxacin—Leukopenia—Sorafenib—liver cancer	0.000426	0.00512	CcSEcCtD
Norfloxacin—Dysarthria—Epirubicin—liver cancer	0.000425	0.00512	CcSEcCtD
Norfloxacin—Jaundice cholestatic—Doxorubicin—liver cancer	0.000423	0.0051	CcSEcCtD
Norfloxacin—Creatinine increased—Epirubicin—liver cancer	0.000422	0.00508	CcSEcCtD
Norfloxacin—Arthralgia—Sorafenib—liver cancer	0.000405	0.00487	CcSEcCtD
Norfloxacin—Myalgia—Sorafenib—liver cancer	0.000405	0.00487	CcSEcCtD
Norfloxacin—Lacrimation increased—Doxorubicin—liver cancer	0.000404	0.00486	CcSEcCtD
Norfloxacin—Phosphatase alkaline increased—Epirubicin—liver cancer	0.000402	0.00484	CcSEcCtD
Norfloxacin—Dry mouth—Sorafenib—liver cancer	0.000396	0.00477	CcSEcCtD
Norfloxacin—Dysarthria—Doxorubicin—liver cancer	0.000393	0.00473	CcSEcCtD
Norfloxacin—Creatinine increased—Doxorubicin—liver cancer	0.000391	0.0047	CcSEcCtD
Norfloxacin—Anaphylactic shock—Sorafenib—liver cancer	0.000388	0.00467	CcSEcCtD
Norfloxacin—Thrombocytopenia—Sorafenib—liver cancer	0.00038	0.00457	CcSEcCtD
Norfloxacin—Blood urea increased—Epirubicin—liver cancer	0.00038	0.00457	CcSEcCtD
Norfloxacin—Phosphatase alkaline increased—Doxorubicin—liver cancer	0.000372	0.00448	CcSEcCtD
Norfloxacin—Anorexia—Sorafenib—liver cancer	0.00037	0.00445	CcSEcCtD
Norfloxacin—Mouth ulceration—Epirubicin—liver cancer	0.000363	0.00438	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000354	0.00426	CcSEcCtD
Norfloxacin—Hypertonia—Epirubicin—liver cancer	0.000352	0.00424	CcSEcCtD
Norfloxacin—Blood urea increased—Doxorubicin—liver cancer	0.000351	0.00423	CcSEcCtD
Norfloxacin—Dyspnoea—Sorafenib—liver cancer	0.000346	0.00417	CcSEcCtD
Norfloxacin—Dyspepsia—Sorafenib—liver cancer	0.000342	0.00411	CcSEcCtD
Norfloxacin—Decreased appetite—Sorafenib—liver cancer	0.000337	0.00406	CcSEcCtD
Norfloxacin—Mouth ulceration—Doxorubicin—liver cancer	0.000336	0.00405	CcSEcCtD
Norfloxacin—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.000336	0.00404	CcSEcCtD
Norfloxacin—Fatigue—Sorafenib—liver cancer	0.000335	0.00403	CcSEcCtD
Norfloxacin—Photosensitivity—Epirubicin—liver cancer	0.000332	0.004	CcSEcCtD
Norfloxacin—Constipation—Sorafenib—liver cancer	0.000332	0.004	CcSEcCtD
Norfloxacin—Hypertonia—Doxorubicin—liver cancer	0.000326	0.00393	CcSEcCtD
Norfloxacin—Hepatic failure—Epirubicin—liver cancer	0.000325	0.00391	CcSEcCtD
Norfloxacin—Eye pain—Epirubicin—liver cancer	0.000323	0.00389	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Sorafenib—liver cancer	0.000317	0.00382	CcSEcCtD
Norfloxacin—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.00031	0.00374	CcSEcCtD
Norfloxacin—Dermatitis exfoliative—Epirubicin—liver cancer	0.000309	0.00372	CcSEcCtD
Norfloxacin—Urticaria—Sorafenib—liver cancer	0.000308	0.00371	CcSEcCtD
Norfloxacin—Photosensitivity—Doxorubicin—liver cancer	0.000308	0.0037	CcSEcCtD
Norfloxacin—Abdominal pain—Sorafenib—liver cancer	0.000307	0.00369	CcSEcCtD
Norfloxacin—Body temperature increased—Sorafenib—liver cancer	0.000307	0.00369	CcSEcCtD
Norfloxacin—Dermatitis bullous—Epirubicin—liver cancer	0.000305	0.00368	CcSEcCtD
Norfloxacin—Anaphylactoid reaction—Epirubicin—liver cancer	0.000302	0.00363	CcSEcCtD
Norfloxacin—Hepatic failure—Doxorubicin—liver cancer	0.0003	0.00362	CcSEcCtD
Norfloxacin—Eye pain—Doxorubicin—liver cancer	0.000299	0.0036	CcSEcCtD
Norfloxacin—Hypoglycaemia—Epirubicin—liver cancer	0.000299	0.0036	CcSEcCtD
Norfloxacin—Diplopia—Epirubicin—liver cancer	0.000292	0.00351	CcSEcCtD
Norfloxacin—Osteoarthritis—Epirubicin—liver cancer	0.000292	0.00351	CcSEcCtD
Norfloxacin—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000286	0.00344	CcSEcCtD
Norfloxacin—Hypersensitivity—Sorafenib—liver cancer	0.000286	0.00344	CcSEcCtD
Norfloxacin—Dermatitis bullous—Doxorubicin—liver cancer	0.000283	0.0034	CcSEcCtD
Norfloxacin—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000279	0.00336	CcSEcCtD
Norfloxacin—Asthenia—Sorafenib—liver cancer	0.000278	0.00335	CcSEcCtD
Norfloxacin—Hypoglycaemia—Doxorubicin—liver cancer	0.000277	0.00333	CcSEcCtD
Norfloxacin—Pruritus—Sorafenib—liver cancer	0.000275	0.00331	CcSEcCtD
Norfloxacin—Ataxia—Epirubicin—liver cancer	0.000274	0.0033	CcSEcCtD
Norfloxacin—Blood creatinine increased—Epirubicin—liver cancer	0.000273	0.00329	CcSEcCtD
Norfloxacin—Osteoarthritis—Doxorubicin—liver cancer	0.00027	0.00325	CcSEcCtD
Norfloxacin—Diplopia—Doxorubicin—liver cancer	0.00027	0.00325	CcSEcCtD
Norfloxacin—Liver function test abnormal—Epirubicin—liver cancer	0.000269	0.00324	CcSEcCtD
Norfloxacin—Orthostatic hypotension—Epirubicin—liver cancer	0.000267	0.00321	CcSEcCtD
Norfloxacin—Diarrhoea—Sorafenib—liver cancer	0.000266	0.0032	CcSEcCtD
Norfloxacin—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000263	0.00316	CcSEcCtD
Norfloxacin—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000263	0.00316	CcSEcCtD
Norfloxacin—Dizziness—Sorafenib—liver cancer	0.000257	0.00309	CcSEcCtD
Norfloxacin—Ataxia—Doxorubicin—liver cancer	0.000254	0.00306	CcSEcCtD
Norfloxacin—Blood creatinine increased—Doxorubicin—liver cancer	0.000253	0.00305	CcSEcCtD
Norfloxacin—Dysphagia—Epirubicin—liver cancer	0.000252	0.00304	CcSEcCtD
Norfloxacin—Eosinophilia—Epirubicin—liver cancer	0.00025	0.00301	CcSEcCtD
Norfloxacin—Liver function test abnormal—Doxorubicin—liver cancer	0.000249	0.003	CcSEcCtD
Norfloxacin—Pancreatitis—Epirubicin—liver cancer	0.000247	0.00298	CcSEcCtD
Norfloxacin—Vomiting—Sorafenib—liver cancer	0.000247	0.00297	CcSEcCtD
Norfloxacin—Orthostatic hypotension—Doxorubicin—liver cancer	0.000247	0.00297	CcSEcCtD
Norfloxacin—Rash—Sorafenib—liver cancer	0.000245	0.00295	CcSEcCtD
Norfloxacin—Dermatitis—Sorafenib—liver cancer	0.000244	0.00294	CcSEcCtD
Norfloxacin—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000243	0.00293	CcSEcCtD
Norfloxacin—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000243	0.00293	CcSEcCtD
Norfloxacin—Headache—Sorafenib—liver cancer	0.000243	0.00293	CcSEcCtD
Norfloxacin—Neutropenia—Epirubicin—liver cancer	0.000236	0.00284	CcSEcCtD
Norfloxacin—Dysphagia—Doxorubicin—liver cancer	0.000233	0.00281	CcSEcCtD
Norfloxacin—Eosinophilia—Doxorubicin—liver cancer	0.000231	0.00278	CcSEcCtD
Norfloxacin—Nausea—Sorafenib—liver cancer	0.000231	0.00278	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Epirubicin—liver cancer	0.00023	0.00277	CcSEcCtD
Norfloxacin—Pancreatitis—Doxorubicin—liver cancer	0.000229	0.00275	CcSEcCtD
Norfloxacin—Drowsiness—Epirubicin—liver cancer	0.000225	0.00271	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000223	0.00268	CcSEcCtD
Norfloxacin—Renal failure—Epirubicin—liver cancer	0.000221	0.00266	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Epirubicin—liver cancer	0.00022	0.00265	CcSEcCtD
Norfloxacin—Stomatitis—Epirubicin—liver cancer	0.000219	0.00264	CcSEcCtD
Norfloxacin—Jaundice—Epirubicin—liver cancer	0.000219	0.00264	CcSEcCtD
Norfloxacin—Conjunctivitis—Epirubicin—liver cancer	0.000219	0.00263	CcSEcCtD
Norfloxacin—Neutropenia—Doxorubicin—liver cancer	0.000218	0.00263	CcSEcCtD
Norfloxacin—Haematuria—Epirubicin—liver cancer	0.000214	0.00258	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Doxorubicin—liver cancer	0.000213	0.00256	CcSEcCtD
Norfloxacin—Agranulocytosis—Epirubicin—liver cancer	0.00021	0.00253	CcSEcCtD
Norfloxacin—Drowsiness—Doxorubicin—liver cancer	0.000208	0.0025	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000206	0.00248	CcSEcCtD
Norfloxacin—Renal failure—Doxorubicin—liver cancer	0.000205	0.00246	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Doxorubicin—liver cancer	0.000204	0.00246	CcSEcCtD
Norfloxacin—Jaundice—Doxorubicin—liver cancer	0.000203	0.00244	CcSEcCtD
Norfloxacin—Stomatitis—Doxorubicin—liver cancer	0.000203	0.00244	CcSEcCtD
Norfloxacin—Conjunctivitis—Doxorubicin—liver cancer	0.000202	0.00243	CcSEcCtD
Norfloxacin—Hepatitis—Epirubicin—liver cancer	0.000202	0.00243	CcSEcCtD
Norfloxacin—Hypoaesthesia—Epirubicin—liver cancer	0.000201	0.00242	CcSEcCtD
Norfloxacin—Haematuria—Doxorubicin—liver cancer	0.000198	0.00239	CcSEcCtD
Norfloxacin—Visual impairment—Epirubicin—liver cancer	0.000195	0.00234	CcSEcCtD
Norfloxacin—Agranulocytosis—Doxorubicin—liver cancer	0.000194	0.00234	CcSEcCtD
Norfloxacin—Erythema multiforme—Epirubicin—liver cancer	0.000191	0.0023	CcSEcCtD
Norfloxacin—Tinnitus—Epirubicin—liver cancer	0.000188	0.00227	CcSEcCtD
Norfloxacin—Hepatitis—Doxorubicin—liver cancer	0.000187	0.00225	CcSEcCtD
Norfloxacin—Hypoaesthesia—Doxorubicin—liver cancer	0.000186	0.00224	CcSEcCtD
Norfloxacin—Chills—Epirubicin—liver cancer	0.000181	0.00218	CcSEcCtD
Norfloxacin—Visual impairment—Doxorubicin—liver cancer	0.00018	0.00217	CcSEcCtD
Norfloxacin—Erythema multiforme—Doxorubicin—liver cancer	0.000177	0.00213	CcSEcCtD
Norfloxacin—Erythema—Epirubicin—liver cancer	0.000176	0.00212	CcSEcCtD
Norfloxacin—Tinnitus—Doxorubicin—liver cancer	0.000174	0.0021	CcSEcCtD
Norfloxacin—Flatulence—Epirubicin—liver cancer	0.000173	0.00208	CcSEcCtD
Norfloxacin—Tension—Epirubicin—liver cancer	0.000172	0.00208	CcSEcCtD
Norfloxacin—Dysgeusia—Epirubicin—liver cancer	0.000172	0.00207	CcSEcCtD
Norfloxacin—Nervousness—Epirubicin—liver cancer	0.000171	0.00205	CcSEcCtD
Norfloxacin—Back pain—Epirubicin—liver cancer	0.00017	0.00205	CcSEcCtD
Norfloxacin—Muscle spasms—Epirubicin—liver cancer	0.000169	0.00203	CcSEcCtD
Norfloxacin—Chills—Doxorubicin—liver cancer	0.000168	0.00202	CcSEcCtD
Norfloxacin—Vision blurred—Epirubicin—liver cancer	0.000166	0.00199	CcSEcCtD
Norfloxacin—Erythema—Doxorubicin—liver cancer	0.000163	0.00196	CcSEcCtD
Norfloxacin—Agitation—Epirubicin—liver cancer	0.000162	0.00194	CcSEcCtD
Norfloxacin—Flatulence—Doxorubicin—liver cancer	0.00016	0.00193	CcSEcCtD
Norfloxacin—Tension—Doxorubicin—liver cancer	0.00016	0.00192	CcSEcCtD
Norfloxacin—Dysgeusia—Doxorubicin—liver cancer	0.000159	0.00192	CcSEcCtD
Norfloxacin—Nervousness—Doxorubicin—liver cancer	0.000158	0.0019	CcSEcCtD
Norfloxacin—Vertigo—Epirubicin—liver cancer	0.000158	0.0019	CcSEcCtD
Norfloxacin—Leukopenia—Epirubicin—liver cancer	0.000157	0.00189	CcSEcCtD
Norfloxacin—Back pain—Doxorubicin—liver cancer	0.000157	0.00189	CcSEcCtD
Norfloxacin—Muscle spasms—Doxorubicin—liver cancer	0.000156	0.00188	CcSEcCtD
Norfloxacin—Palpitations—Epirubicin—liver cancer	0.000155	0.00187	CcSEcCtD
Norfloxacin—Vision blurred—Doxorubicin—liver cancer	0.000153	0.00184	CcSEcCtD
Norfloxacin—Convulsion—Epirubicin—liver cancer	0.000152	0.00183	CcSEcCtD
Norfloxacin—Arthralgia—Epirubicin—liver cancer	0.00015	0.0018	CcSEcCtD
Norfloxacin—Chest pain—Epirubicin—liver cancer	0.00015	0.0018	CcSEcCtD
Norfloxacin—Myalgia—Epirubicin—liver cancer	0.00015	0.0018	CcSEcCtD
Norfloxacin—Agitation—Doxorubicin—liver cancer	0.000149	0.0018	CcSEcCtD
Norfloxacin—Anxiety—Epirubicin—liver cancer	0.000149	0.00179	CcSEcCtD
Norfloxacin—Dry mouth—Epirubicin—liver cancer	0.000146	0.00176	CcSEcCtD
Norfloxacin—Vertigo—Doxorubicin—liver cancer	0.000146	0.00176	CcSEcCtD
Norfloxacin—Leukopenia—Doxorubicin—liver cancer	0.000146	0.00175	CcSEcCtD
Norfloxacin—Confusional state—Epirubicin—liver cancer	0.000145	0.00174	CcSEcCtD
Norfloxacin—Palpitations—Doxorubicin—liver cancer	0.000144	0.00173	CcSEcCtD
Norfloxacin—Oedema—Epirubicin—liver cancer	0.000143	0.00173	CcSEcCtD
Norfloxacin—Anaphylactic shock—Epirubicin—liver cancer	0.000143	0.00173	CcSEcCtD
Norfloxacin—Convulsion—Doxorubicin—liver cancer	0.000141	0.0017	CcSEcCtD
Norfloxacin—Thrombocytopenia—Epirubicin—liver cancer	0.00014	0.00169	CcSEcCtD
Norfloxacin—Hyperhidrosis—Epirubicin—liver cancer	0.000139	0.00167	CcSEcCtD
Norfloxacin—Chest pain—Doxorubicin—liver cancer	0.000138	0.00167	CcSEcCtD
Norfloxacin—Myalgia—Doxorubicin—liver cancer	0.000138	0.00167	CcSEcCtD
Norfloxacin—Arthralgia—Doxorubicin—liver cancer	0.000138	0.00167	CcSEcCtD
Norfloxacin—Anxiety—Doxorubicin—liver cancer	0.000138	0.00166	CcSEcCtD
Norfloxacin—Anorexia—Epirubicin—liver cancer	0.000137	0.00165	CcSEcCtD
Norfloxacin—Dry mouth—Doxorubicin—liver cancer	0.000135	0.00163	CcSEcCtD
Norfloxacin—Confusional state—Doxorubicin—liver cancer	0.000134	0.00161	CcSEcCtD
Norfloxacin—Oedema—Doxorubicin—liver cancer	0.000133	0.0016	CcSEcCtD
Norfloxacin—Anaphylactic shock—Doxorubicin—liver cancer	0.000133	0.0016	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000131	0.00157	CcSEcCtD
Norfloxacin—Thrombocytopenia—Doxorubicin—liver cancer	0.00013	0.00156	CcSEcCtD
Norfloxacin—Insomnia—Epirubicin—liver cancer	0.00013	0.00156	CcSEcCtD
Norfloxacin—Paraesthesia—Epirubicin—liver cancer	0.000129	0.00155	CcSEcCtD
Norfloxacin—Hyperhidrosis—Doxorubicin—liver cancer	0.000128	0.00154	CcSEcCtD
Norfloxacin—Dyspnoea—Epirubicin—liver cancer	0.000128	0.00154	CcSEcCtD
Norfloxacin—Somnolence—Epirubicin—liver cancer	0.000128	0.00153	CcSEcCtD
Norfloxacin—Anorexia—Doxorubicin—liver cancer	0.000127	0.00152	CcSEcCtD
Norfloxacin—Dyspepsia—Epirubicin—liver cancer	0.000126	0.00152	CcSEcCtD
Norfloxacin—Decreased appetite—Epirubicin—liver cancer	0.000125	0.0015	CcSEcCtD
Norfloxacin—Fatigue—Epirubicin—liver cancer	0.000124	0.00149	CcSEcCtD
Norfloxacin—Constipation—Epirubicin—liver cancer	0.000123	0.00148	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000121	0.00146	CcSEcCtD
Norfloxacin—Insomnia—Doxorubicin—liver cancer	0.00012	0.00144	CcSEcCtD
Norfloxacin—Paraesthesia—Doxorubicin—liver cancer	0.000119	0.00143	CcSEcCtD
Norfloxacin—Dyspnoea—Doxorubicin—liver cancer	0.000118	0.00142	CcSEcCtD
Norfloxacin—Feeling abnormal—Epirubicin—liver cancer	0.000118	0.00142	CcSEcCtD
Norfloxacin—Somnolence—Doxorubicin—liver cancer	0.000118	0.00142	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Epirubicin—liver cancer	0.000117	0.00141	CcSEcCtD
Norfloxacin—Dyspepsia—Doxorubicin—liver cancer	0.000117	0.00141	CcSEcCtD
Norfloxacin—Decreased appetite—Doxorubicin—liver cancer	0.000115	0.00139	CcSEcCtD
Norfloxacin—Fatigue—Doxorubicin—liver cancer	0.000114	0.00138	CcSEcCtD
Norfloxacin—Urticaria—Epirubicin—liver cancer	0.000114	0.00137	CcSEcCtD
Norfloxacin—Constipation—Doxorubicin—liver cancer	0.000113	0.00137	CcSEcCtD
Norfloxacin—Abdominal pain—Epirubicin—liver cancer	0.000113	0.00136	CcSEcCtD
Norfloxacin—Body temperature increased—Epirubicin—liver cancer	0.000113	0.00136	CcSEcCtD
Norfloxacin—Feeling abnormal—Doxorubicin—liver cancer	0.000109	0.00132	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Doxorubicin—liver cancer	0.000109	0.00131	CcSEcCtD
Norfloxacin—Hypersensitivity—Epirubicin—liver cancer	0.000106	0.00127	CcSEcCtD
Norfloxacin—Urticaria—Doxorubicin—liver cancer	0.000105	0.00127	CcSEcCtD
Norfloxacin—Abdominal pain—Doxorubicin—liver cancer	0.000105	0.00126	CcSEcCtD
Norfloxacin—Body temperature increased—Doxorubicin—liver cancer	0.000105	0.00126	CcSEcCtD
Norfloxacin—Asthenia—Epirubicin—liver cancer	0.000103	0.00124	CcSEcCtD
Norfloxacin—Pruritus—Epirubicin—liver cancer	0.000101	0.00122	CcSEcCtD
Norfloxacin—Diarrhoea—Epirubicin—liver cancer	9.81e-05	0.00118	CcSEcCtD
Norfloxacin—Hypersensitivity—Doxorubicin—liver cancer	9.78e-05	0.00118	CcSEcCtD
Norfloxacin—Asthenia—Doxorubicin—liver cancer	9.52e-05	0.00115	CcSEcCtD
Norfloxacin—Dizziness—Epirubicin—liver cancer	9.49e-05	0.00114	CcSEcCtD
Norfloxacin—Pruritus—Doxorubicin—liver cancer	9.39e-05	0.00113	CcSEcCtD
Norfloxacin—Vomiting—Epirubicin—liver cancer	9.12e-05	0.0011	CcSEcCtD
Norfloxacin—Diarrhoea—Doxorubicin—liver cancer	9.08e-05	0.00109	CcSEcCtD
Norfloxacin—Rash—Epirubicin—liver cancer	9.04e-05	0.00109	CcSEcCtD
Norfloxacin—Dermatitis—Epirubicin—liver cancer	9.04e-05	0.00109	CcSEcCtD
Norfloxacin—Headache—Epirubicin—liver cancer	8.99e-05	0.00108	CcSEcCtD
Norfloxacin—Dizziness—Doxorubicin—liver cancer	8.78e-05	0.00106	CcSEcCtD
Norfloxacin—Nausea—Epirubicin—liver cancer	8.52e-05	0.00103	CcSEcCtD
Norfloxacin—Vomiting—Doxorubicin—liver cancer	8.44e-05	0.00102	CcSEcCtD
Norfloxacin—Rash—Doxorubicin—liver cancer	8.37e-05	0.00101	CcSEcCtD
Norfloxacin—Dermatitis—Doxorubicin—liver cancer	8.36e-05	0.00101	CcSEcCtD
Norfloxacin—Headache—Doxorubicin—liver cancer	8.31e-05	0.001	CcSEcCtD
Norfloxacin—Nausea—Doxorubicin—liver cancer	7.88e-05	0.000949	CcSEcCtD
Norfloxacin—CYP1A2—Metapathway biotransformation—GSTP1—liver cancer	3.46e-05	0.000487	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—TAT—liver cancer	3.38e-05	0.000476	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—EPT1—liver cancer	3.37e-05	0.000474	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—IL6—liver cancer	3.32e-05	0.000468	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—liver cancer	3.29e-05	0.000463	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—CYP2E1—liver cancer	3.28e-05	0.000462	CbGpPWpGaD
Norfloxacin—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	3.24e-05	0.000455	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—GSTM1—liver cancer	3.22e-05	0.000453	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	3.19e-05	0.000449	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—TAT—liver cancer	3.19e-05	0.000449	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CPT1B—liver cancer	3.18e-05	0.000447	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GLUL—liver cancer	3.18e-05	0.000447	CbGpPWpGaD
Norfloxacin—CYP1A2—Metapathway biotransformation—GSTM1—liver cancer	3.18e-05	0.000447	CbGpPWpGaD
Norfloxacin—CYP2A6—NRF2 pathway—TGFB1—liver cancer	3.15e-05	0.000444	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	3.14e-05	0.000442	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	3.11e-05	0.000437	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—NR1H4—liver cancer	3.06e-05	0.000431	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—CYP1A1—liver cancer	3.05e-05	0.00043	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GSTA3—liver cancer	3.01e-05	0.000424	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—GGT1—liver cancer	3.01e-05	0.000424	CbGpPWpGaD
Norfloxacin—CYP1A2—Metapathway biotransformation—CYP1A1—liver cancer	3.01e-05	0.000424	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	3e-05	0.000422	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	2.97e-05	0.000418	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDKN2A—liver cancer	2.94e-05	0.000414	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—liver cancer	2.91e-05	0.00041	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CPT1B—liver cancer	2.91e-05	0.00041	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GLUL—liver cancer	2.91e-05	0.00041	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—NR1H4—liver cancer	2.81e-05	0.000395	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—PPARA—liver cancer	2.81e-05	0.000395	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—liver cancer	2.78e-05	0.000391	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—liver cancer	2.76e-05	0.000389	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTA3—liver cancer	2.76e-05	0.000389	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GSTA4—liver cancer	2.76e-05	0.000388	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—GSTP1—liver cancer	2.71e-05	0.000381	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—liver cancer	2.69e-05	0.000378	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GSTA2—liver cancer	2.69e-05	0.000378	CbGpPWpGaD
Norfloxacin—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	2.67e-05	0.000376	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDKN1B—liver cancer	2.6e-05	0.000367	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GSTA1—liver cancer	2.59e-05	0.000365	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—NAT2—liver cancer	2.56e-05	0.000361	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTA4—liver cancer	2.53e-05	0.000355	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—RAF1—liver cancer	2.5e-05	0.000352	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—GSTM1—liver cancer	2.49e-05	0.00035	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CCND1—liver cancer	2.49e-05	0.00035	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTA2—liver cancer	2.46e-05	0.000346	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ALDOB—liver cancer	2.46e-05	0.000346	CbGpPWpGaD
Norfloxacin—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	2.45e-05	0.000345	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDKN1A—liver cancer	2.4e-05	0.000338	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTA1—liver cancer	2.37e-05	0.000334	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—CYP1A1—liver cancer	2.36e-05	0.000332	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	2.35e-05	0.000331	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—NAT2—liver cancer	2.35e-05	0.00033	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CRABP1—liver cancer	2.34e-05	0.00033	CbGpPWpGaD
Norfloxacin—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	2.32e-05	0.000327	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CPT1B—liver cancer	2.3e-05	0.000323	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GLUL—liver cancer	2.3e-05	0.000323	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	2.29e-05	0.000322	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—UGDH—liver cancer	2.28e-05	0.000321	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ALDOB—liver cancer	2.25e-05	0.000317	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—MYC—liver cancer	2.23e-05	0.000314	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—NR1H4—liver cancer	2.22e-05	0.000312	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTA3—liver cancer	2.18e-05	0.000307	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CPT1B—liver cancer	2.17e-05	0.000305	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GLUL—liver cancer	2.17e-05	0.000305	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CRABP1—liver cancer	2.15e-05	0.000302	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—EPT1—liver cancer	2.15e-05	0.000302	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NR1H4—liver cancer	2.09e-05	0.000295	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—ALB—liver cancer	2.08e-05	0.000293	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTA3—liver cancer	2.06e-05	0.00029	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—HPGDS—liver cancer	2.05e-05	0.000288	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—TAT—liver cancer	2.04e-05	0.000287	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	2e-05	0.000282	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—MYC—liver cancer	1.99e-05	0.000281	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTA4—liver cancer	1.99e-05	0.00028	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTA2—liver cancer	1.94e-05	0.000273	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—RAF1—liver cancer	1.89e-05	0.000265	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTA4—liver cancer	1.88e-05	0.000265	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—HPGDS—liver cancer	1.88e-05	0.000264	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTA1—liver cancer	1.87e-05	0.000264	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—NAT2—liver cancer	1.85e-05	0.000261	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTA2—liver cancer	1.83e-05	0.000258	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PSMD10—liver cancer	1.83e-05	0.000257	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PSMA4—liver cancer	1.83e-05	0.000257	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GOT2—liver cancer	1.78e-05	0.00025	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ALDOB—liver cancer	1.78e-05	0.00025	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTA1—liver cancer	1.77e-05	0.000249	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—UGDH—liver cancer	1.76e-05	0.000248	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NAT2—liver cancer	1.75e-05	0.000246	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CRABP1—liver cancer	1.69e-05	0.000238	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.68e-05	0.000237	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ALDOB—liver cancer	1.68e-05	0.000236	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PSMA4—liver cancer	1.67e-05	0.000235	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PSMD10—liver cancer	1.67e-05	0.000235	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CYP2E1—liver cancer	1.67e-05	0.000235	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—EPT1—liver cancer	1.66e-05	0.000233	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—TP53—liver cancer	1.64e-05	0.00023	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GOT2—liver cancer	1.63e-05	0.000229	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CRABP1—liver cancer	1.6e-05	0.000225	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—TAT—liver cancer	1.57e-05	0.000221	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CYCS—liver cancer	1.56e-05	0.00022	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GGT1—liver cancer	1.53e-05	0.000216	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GOT1—liver cancer	1.53e-05	0.000216	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CYP2E1—liver cancer	1.53e-05	0.000215	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	1.5e-05	0.000211	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—HPGDS—liver cancer	1.48e-05	0.000208	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.44e-05	0.000203	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CYCS—liver cancer	1.43e-05	0.000202	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GOT1—liver cancer	1.41e-05	0.000198	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GGT1—liver cancer	1.41e-05	0.000198	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—HPGDS—liver cancer	1.4e-05	0.000197	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.39e-05	0.000196	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GLUL—liver cancer	1.38e-05	0.000195	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CPT1B—liver cancer	1.38e-05	0.000195	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GSTP1—liver cancer	1.38e-05	0.000194	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—HMOX1—liver cancer	1.36e-05	0.000191	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NR1H4—liver cancer	1.33e-05	0.000188	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PSMD10—liver cancer	1.32e-05	0.000186	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PSMA4—liver cancer	1.32e-05	0.000186	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTA3—liver cancer	1.31e-05	0.000185	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GOT2—liver cancer	1.28e-05	0.000181	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.27e-05	0.000178	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GSTM1—liver cancer	1.27e-05	0.000178	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTP1—liver cancer	1.26e-05	0.000178	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.25e-05	0.000176	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PSMA4—liver cancer	1.25e-05	0.000175	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PSMD10—liver cancer	1.25e-05	0.000175	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—HMOX1—liver cancer	1.24e-05	0.000175	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GOT2—liver cancer	1.21e-05	0.000171	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP2E1—liver cancer	1.21e-05	0.00017	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTA4—liver cancer	1.2e-05	0.000169	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CYP1A1—liver cancer	1.2e-05	0.000169	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.17e-05	0.000165	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTA2—liver cancer	1.17e-05	0.000165	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTM1—liver cancer	1.16e-05	0.000163	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYP2E1—liver cancer	1.14e-05	0.00016	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYCS—liver cancer	1.13e-05	0.000159	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTA1—liver cancer	1.13e-05	0.000159	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—MTHFR—liver cancer	1.12e-05	0.000157	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NAT2—liver cancer	1.12e-05	0.000157	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GGT1—liver cancer	1.11e-05	0.000156	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GOT1—liver cancer	1.11e-05	0.000156	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.1e-05	0.000155	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CYP1A1—liver cancer	1.1e-05	0.000155	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PPARA—liver cancer	1.1e-05	0.000154	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.07e-05	0.000151	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ALDOB—liver cancer	1.07e-05	0.000151	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CPT1B—liver cancer	1.07e-05	0.00015	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GLUL—liver cancer	1.07e-05	0.00015	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYCS—liver cancer	1.07e-05	0.00015	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GGT1—liver cancer	1.05e-05	0.000147	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GOT1—liver cancer	1.05e-05	0.000147	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NR1H4—liver cancer	1.03e-05	0.000145	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—MTHFR—liver cancer	1.02e-05	0.000144	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CRABP1—liver cancer	1.02e-05	0.000144	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTA3—liver cancer	1.01e-05	0.000143	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PPARA—liver cancer	1.01e-05	0.000142	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTP1—liver cancer	9.95e-06	0.00014	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—HMOX1—liver cancer	9.82e-06	0.000138	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTP1—liver cancer	9.4e-06	0.000132	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3CG—liver cancer	9.4e-06	0.000132	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—HMOX1—liver cancer	9.27e-06	0.000131	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTA4—liver cancer	9.26e-06	0.00013	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	9.19e-06	0.000129	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTM1—liver cancer	9.15e-06	0.000129	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PPARG—liver cancer	9.07e-06	0.000128	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTA2—liver cancer	9.02e-06	0.000127	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—HPGDS—liver cancer	8.92e-06	0.000126	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	8.87e-06	0.000125	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTA1—liver cancer	8.71e-06	0.000123	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP1A1—liver cancer	8.67e-06	0.000122	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTM1—liver cancer	8.64e-06	0.000122	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3CG—liver cancer	8.61e-06	0.000121	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NAT2—liver cancer	8.61e-06	0.000121	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PPARG—liver cancer	8.31e-06	0.000117	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3CD—liver cancer	8.26e-06	0.000116	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ALDOB—liver cancer	8.25e-06	0.000116	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ALB—liver cancer	8.15e-06	0.000115	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—MTHFR—liver cancer	8.08e-06	0.000114	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	8.08e-06	0.000114	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	7.97e-06	0.000112	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PSMD10—liver cancer	7.95e-06	0.000112	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PSMA4—liver cancer	7.95e-06	0.000112	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PPARA—liver cancer	7.93e-06	0.000112	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CRABP1—liver cancer	7.87e-06	0.000111	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GOT2—liver cancer	7.73e-06	0.000109	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—MTHFR—liver cancer	7.64e-06	0.000107	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3CD—liver cancer	7.57e-06	0.000107	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PPARA—liver cancer	7.49e-06	0.000105	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ALB—liver cancer	7.47e-06	0.000105	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP2E1—liver cancer	7.27e-06	0.000102	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3CB—liver cancer	7.2e-06	0.000101	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.04e-06	9.91e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HPGDS—liver cancer	6.88e-06	9.69e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYCS—liver cancer	6.8e-06	9.57e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3CG—liver cancer	6.79e-06	9.56e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.73e-06	9.47e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GGT1—liver cancer	6.67e-06	9.39e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GOT1—liver cancer	6.67e-06	9.39e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3CB—liver cancer	6.6e-06	9.29e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PPARG—liver cancer	6.55e-06	9.23e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PIK3CG—liver cancer	6.42e-06	9.03e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PPARG—liver cancer	6.19e-06	8.72e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PSMD10—liver cancer	6.13e-06	8.63e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PSMA4—liver cancer	6.13e-06	8.63e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTP1—liver cancer	6e-06	8.44e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3CD—liver cancer	5.97e-06	8.4e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GOT2—liver cancer	5.97e-06	8.4e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—HMOX1—liver cancer	5.91e-06	8.32e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ALB—liver cancer	5.89e-06	8.29e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PIK3CD—liver cancer	5.64e-06	7.94e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP2E1—liver cancer	5.61e-06	7.9e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ALB—liver cancer	5.57e-06	7.84e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTM1—liver cancer	5.51e-06	7.75e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYCS—liver cancer	5.25e-06	7.39e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP1A1—liver cancer	5.22e-06	7.35e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3CB—liver cancer	5.2e-06	7.32e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GOT1—liver cancer	5.15e-06	7.25e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GGT1—liver cancer	5.15e-06	7.25e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PIK3CB—liver cancer	4.92e-06	6.92e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—MTHFR—liver cancer	4.87e-06	6.85e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PPARA—liver cancer	4.78e-06	6.72e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTP1—liver cancer	4.63e-06	6.51e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HMOX1—liver cancer	4.56e-06	6.42e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3CA—liver cancer	4.39e-06	6.18e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.29e-06	6.04e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTM1—liver cancer	4.25e-06	5.98e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3CG—liver cancer	4.09e-06	5.76e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP1A1—liver cancer	4.03e-06	5.67e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3CA—liver cancer	4.02e-06	5.66e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PPARG—liver cancer	3.95e-06	5.56e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—MTHFR—liver cancer	3.76e-06	5.29e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PPARA—liver cancer	3.69e-06	5.19e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3CD—liver cancer	3.6e-06	5.06e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—AKT1—liver cancer	3.59e-06	5.05e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ALB—liver cancer	3.55e-06	5e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—AKT1—liver cancer	3.29e-06	4.62e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3CA—liver cancer	3.17e-06	4.46e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3CG—liver cancer	3.16e-06	4.44e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3CB—liver cancer	3.13e-06	4.41e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PPARG—liver cancer	3.05e-06	4.29e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PIK3CA—liver cancer	3e-06	4.22e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3CD—liver cancer	2.78e-06	3.91e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ALB—liver cancer	2.74e-06	3.86e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—AKT1—liver cancer	2.59e-06	3.65e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—AKT1—liver cancer	2.45e-06	3.45e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3CB—liver cancer	2.42e-06	3.4e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3CA—liver cancer	1.91e-06	2.69e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—AKT1—liver cancer	1.56e-06	2.2e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3CA—liver cancer	1.47e-06	2.08e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—AKT1—liver cancer	1.2e-06	1.7e-05	CbGpPWpGaD
